The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) (NCT05820087)

🧪 Interventions in This Study

• HistoSonics Edison System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (15 Sites)

• University of Southern California — Los Angeles, California
• University of California, Los Angeles (UCLA) — Los Angeles, California
• Providence Mission Hosptial — Mission Viejo, California
• Yale School of Medicine — New Haven, Connecticut
• AdventHealth Celebration — Celebration, Florida
• Johns Hopkins University — Baltimore, Maryland
• Massachusetts General Hospital — Boston, Massachusetts
• Northwell Health — Lake Success, New York
• NYU Langone Health — New York, New York
• Icahn School of Medicine Mount Sinai — New York, New York
• University of Rochester Medical Center — Rochester, New York
• The Ohio State University Comprehensive Cancer Center — Columbus, Ohio
• UT Southwestern Medical Center — Dallas, Texas
• Swedish Medical Center — Seattle, Washington
• University of Wisconsin School of Medicine and Public Health — Madison, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Renal Cancer

• Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment — Los Angeles, California
• Advanced Diffusion Imaging in Renal Cancer Patients — New York, New York
• Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) — La Jolla, California
• Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma — New York, New York
• Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus — Aurora, Colorado

Explore by condition: All Renal Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.